CDX
THP-1
Tumor indication
Leukemia
Tumor subtype
Acute Monocytic Leukemia (AML)
Description
THP-1 (Leukemia CDX Model)
The THP-1 line was derived from a patient with acute monocytic leukemia. It is a suspension cell line with features of monocyte lineage. THP-1 is widely used in hematology drug development and biomarker studies. Its reproducibility supports translational leukemia pipelines.
Key Features:
- Derived from acute monocytic leukemia.
- Monocyte lineage markers.
- Suspension growth morphology.
- Tumorigenic in xenografts.
Applications:
THP-1 supports drug discovery in monocytic leukemia. Researchers use it to study differentiation, resistance, and biomarker development. It is also applied in immunology studies due to monocyte lineage properties. Its stability makes it widely adopted in hematology research.
Details
- Tumor indication
- Leukemia
- Tumor subtype
- Acute Monocytic Leukemia (AML)
- Organism
- Human
- Mouse sex
- Female
- Lumin data
- RNA-Seq, WES
Mutated genes
Select a gene to see the variants recorded for this line.
Gene expression
Show all values
| Gene | Expression |
|---|
Expression measured across the Champions panel.
Request this cell line
Let's build the right study, together.
Backed by deep expertise in these models, our team will work with you to design the study around your target, line of therapy, and endpoint.